Alnylam Pharmaceuticals
Case Manager
PayCompetitive
LocationCambridge/Massachusetts
Employment typeFull-Time
This job is now closed
Job Description
- Req#: 74256
Overview We are continuing to build out our US Patient Services team to provide exceptional customer service on all levels. Reporting to a Regional Manager, the Case Manager (CM) will be a critical component of the commercial strategy and work in close coordination with Field Sales, Field Reimbursement, Patient Education Liaisons and Patient Advocacy Teams to support Alnylam’s patient-focused vision of harnessing a revolution in biology for human health®. U.S. Patient Services seeks experienced, passionate, patient-focused individuals committed to improving the lives of those living with hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis), acute hepatic porphyrias (AHP) and primary hyperoxaluria (PH). The CM will be responsible for interfacing with patients affected by these rare diseases, their caregivers, and healthcare providers (HCPs), to facilitate access to treatment. The CM will work collaboratively with internal and external stakeholders to support individual patients’ needs through personalized, compassionate communication and high-touch services. He/she is responsible for engaging multiple stakeholders in support of helping appropriate patients initiate and stay on therapy. The CM focuses on identifying and coordinating various services that individual patients may need to get access to therapy and addressing reimbursement barriers that prevent the individual from remaining on therapy. The successful candidate must exhibit a positive attitude, be passionate about science and deeply motivated by the quest of delivering value to patients and their families with the long-term success of the company in mind. He/she will be responsible for providing a smooth customer interaction from initial intake through supporting continued patient access to therapy. He/she will manage the logistical issues impacting treatment initiation and ongoing therapy. The CM demonstrates understanding of the company’s business objectives and measures and demonstrates strengths working independently as well as collaboratively within a highly matrixed environment. Key Responsibilities - Assesses patients’ needs and develops action plans that provide for the initiation and continuation of treatment with Alnylam products while coordinating the exchange of all applicable patient-related information with appropriate internal and external stakeholders. - Develops a comprehensive understanding of the reimbursement process, billing/coding nuances, insurance plans, payer trends, financial assistance programs, patient assistance programs, and related resources. - Assists in obtaining insurance approval for Alnylam products, and proactively plans for maintenance of coverage by working with patients and their caregivers/families, healthcare providers, insurance companies, specialty pharmacies, and Alnylam colleagues. - Understands the resources available in their specific region, and how they can be best employed to support patient care. - Identifies complex patient-specific issues and develops and executes action plans accordingly. - Maintains disease, reimbursement and insurance coverage expertise through continuing medical education and attendance at relevant conferences and other educational opportunities. - Educates patients, caregivers, family members, health care providers, and others regarding insurance options and limitations, including requirements necessary to initiate and maintain treatment, patient services’ offerings and relevant disease/product information as necessary. - Fosters collaborative relationships with all internal and external customers including but not limited to patient education liaisons, medical, sales, field reimbursement, corporate accounts, patient advocacy, insurance company case managers, specialty pharmacies, home health agencies, and office coordinators. - Maintains accurate data on each individual, their insurance, coverage approvals, on-going coverage requirements and all patient and provider interactions. - Attend patient meetings and represent Alnylam at industry conferences, as needed - Ensures compliance with all corporate and industry policies in collaboration with Alnylam Legal, Regulatory and Compliance. Qualifications - Bachelor’s Degree required. Health Care/Social Work/Nursing (or related field) a plus. - 3+ years recent case management experience in the healthcare or pharmaceutical/biotech industry. Ultra-rare disease experience a plus. - Experience should include but not be limited to home care management, case management review, utilization review, social service support, insurance reimbursement, patient assistance programs, or billing and coding. - Knowledge of benefit verification and prior authorization process for infused and injectable products. - Knowledge of private payer, Medicare, and Medicaid structure, systems, and reimbursement process required. - Experience and proficiency in working with a Customer Relationship Management System, such as Salesforce.com. - Possess strong written and verbal communication skills, exceptional listening, critical thinking, problem solving, negotiation and mediation skills. - Ability to navigate difficult conversations and handle sensitive issues with opposing opinions. - Ability to work independently and manage competing priorities - Experience working in cross-functional teams and effective in influencing without authority. - Desire to innovate and work in a fast-paced, flexible, and energetic environment. - Self-starter who is highly passionate about rare disease and Alnylam’s core values:-- Commitment to People, Innovation and Discovery, Sense of Urgency, Open Culture, and Passion for Excellence - Ability to travel 5%, including weekends/evenings, as needed. About Alnylam Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality. Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2022, one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2023 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others. At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law. Alnylam is an E-Verify employer.About the company
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases.